Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine Expert Forum
Time：10:00 Mar. 19th (Tuesday)
Venue：E228
Chair：Prof. Jiekai Chen
1、Safe and Universal Stem Cell Source for Off-the-Shelf Therapeutic Cell Products
Speaker: Prof. Andras Nagy
Dr. Nagy is currently a Shawn Kimel Senior Scientist at the Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Professor in the Department of Obstetrics & Gynaecology and Institute of Medical Science at the University of Toronto and Professor at the Australian Regenerative Medicine Institute in Monash University, Melbourne. He holds a Tier I Canada Research Chair in Stem Cells and Regeneration. He is a Fellow of the Royal Society of Canada in the Life Sciences Division of the Academy of Science. Dr. Nagy is also a Foreign Member of the Hungarian Academy of Science, an Honorary Professor at the Helsinki University, and a Distinguished Professor at the Honk Kong University.Dr.Nagy‘s team created the first Canadian human embryonic stem cell lines in early 2000. In 2009, they developed the first method allowing the generation of iPS cell lines without any genetic change. His current research has become even more translational by addressing and coming up with solutions for two significant hurdles of cell therapies: safety and allogeneic cell acceptance without the need for suppression of the immune system. His research has been aiming to advance medicine with a focus to treat incurable degenerative diseases.
2、Finding and making the right cells for articular cartilage repair
Speaker: Prof. CHAN Danny
Danny Chan is a professor and Director of the School of Biomedical Science at the University of Hong Kong. His research interest is in skeletal biology, focusing on development, growth, and degenerative processes of the skeleton. He has a particular interest in rare diseases. His research has contributed to key understandings in cartilage/bone development and growth, in health and disease. The emphasis is on genes regulating the linear growth of long bones, the formation of a synovial joint, and the intervertebral disc of the spine. The approach is to identify novel disease genes and to model the disease in mice to define the precise molecular and developmental changes. He leverages on the scientific discoveries to formulate therapeutic strategies in stem cell and regenerative medicine. He is passionate in community outreach, supporting patients with rare diseases. He helped to establish the “The Little People of Hong Kong” foundation, and is also a founding council member of Rare Disease Hong Kong (RDHK), advocating for the needs of all rare disease patients in our society for more than a decade.
